Extracellular matrix modulating agent
MYPI2025004123A0Undetermined Publication Date: 2020-08-28KOWA CO LTD +2
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025004123
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-09-30
- Filing Date
- 2020-02-27
- Publication Date
- 2020-08-28
Abstract
The present invention provide an agent for modulating expression of extracellular matrix by corneal endothelial cells. The present invention pertains to an agent for modulating expression of extracellular matrix by corneal endothelial cells containing, 1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine or a salt thereof, or a solvate thereof. Figure 1
Need to check novelty before this filing date? Find Prior Art
